Tao Wang, PhD

Publications

• Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry.

  (Gillis N, Padron E, Wang T, Chen K, DeVos JD, Spellman SR, Lee SJ, Kitko CL, MacMillan ML, West J, Tang YH, Teng M, McNulty S, Druley TE, Pidala JA, Lazaryan A.) Transplant Cell Ther. 2023 Oct;29(10):640.e1-640.e8 PMID: 37517612 PMCID: PMC10592088 SCOPUS ID: 2-s2.0-85168489401 07/31/2023

• Endpoint selection and evaluation in hematology studies.

  (Brazauskas R, Eapen M, Wang T.) Best Pract Res Clin Haematol. 2023 Sep;36(3):101479 PMID: 37611997 SCOPUS ID: 2-s2.0-85161313534 08/24/2023

• On asymptotic distributions of several test statistics for familial relatedness in linear mixed models.

  (Devogel N, Auer PL, Manansala R, Wang T.) Stat Med. 2023 Jul 30;42(17):2962-2981 PMID: 37345498 SCOPUS ID: 2-s2.0-85158096218 06/22/2023

• HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia.

  (Narayan R, Niroula A, Wang T, Kuxhausen M, He M, Meyer E, Chen YB, Bhatt VR, Beitinjaneh A, Nishihori T, Sharma A, Brown VI, Kamoun M, Diaz MA, Abid MB, Askar M, Kanakry CG, Gragert L, Bolon YT, Marsh SGE, Gadalla SM, Paczesny S, Spellman S, Lee SJ.) Transplant Cell Ther. 2023 Jul;29(7):452.e1-452.e11 PMID: 36997024 PMCID: PMC10330307 SCOPUS ID: 2-s2.0-85158827278 03/31/2023

• Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation.

  (Crivello P, Arrieta-Bolaños E, He M, Wang T, Fingerson S, Gadalla SM, Paczesny S, Marsh SGE, Lee SJ, Spellman SR, Bolon YT, Fleischhauer K.) J Clin Oncol. 2023 May 01;41(13):2416-2427 PMID: 36669145 PMCID: PMC10150892 SCOPUS ID: 2-s2.0-85159250781 01/21/2023

• Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas.

  (Mussetti A, Kanate AS, Wang T, He M, Hamadani M, Finel H Sr, Boumendil A Sr, Glass B, Castagna L, Dominietto A, McGuirk J, Blaise D, Gülbas Z, Diez-Martin J, Marsh SGE, Paczesny S, Gadalla SM, Dreger P, Zhang MJ, Spellman SR, Lee SJ, Bolon YT, Sureda A.) Transplant Cell Ther. 2023 Mar;29(3):184.e1-184.e9 PMID: 36577482 PMCID: PMC10316698 SCOPUS ID: 2-s2.0-85146900314 12/29/2022

• Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.

  (Lee CJ, Wang T, Chen K, Arora M, Brazauskas R, Spellman SR, Kitko C, MacMillan ML, Pidala JA, Auletta JJ, Badawy SM, Bhatt N, Bhatt VR, Cahn JY, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla S, Gale RP, Hashem H, Hashmi S, Hematti P, Hong S, Hossain NM, Inamoto Y, Lekakis LJ, Modi D, Patel S, Sharma A, Solomon S, Couriel DR.) Transplant Cell Ther. 2022 Oct;28(10):712.e1-712.e8 PMID: 35863740 PMCID: PMC9547959 SCOPUS ID: 2-s2.0-85136151813 07/22/2022

• Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.

  (Saliba RM, Alousi AM, Pidala J, Arora M, Spellman SR, Hemmer MT, Wang T, Abboud C, Ahmed S, Antin JH, Beitinjaneh A, Buchbinder D, Byrne M, Cahn JY, Choe H, Hanna R, Hematti P, Kamble RT, Kitko CL, Laughlin M, Lekakis L, MacMillan ML, Martino R, Mehta PA, Nishihori T, Patel SS, Perales MA, Rangarajan HG, Ringdén O, Rosenthal J, Savani BN, Schultz KR, Seo S, Teshima T, van der Poel M, Verdonck LF, Weisdorf D, Wirk B, Yared JA, Schriber J, Champlin RE, Ciurea SO.) Transplant Cell Ther. 2022 Oct;28(10):681-693 PMID: 35853610 PMCID: PMC10141544 SCOPUS ID: 2-s2.0-85137041583 07/20/2022

• Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis.

  (Brown DW, Zhou W, Wang Y, Jones K, Luo W, Dagnall C, Teshome K, Klein A, Zhang T, Lin SH, Lee OW, Khan S, Vo JB, Hutchinson A, Liu J, Wang J, Zhu B, Hicks B, Martin AS, Spellman SR, Wang T, Deeg HJ, Gupta V, Lee SJ, Freedman ND, Yeager M, Chanock SJ, Savage SA, Saber W, Gadalla SM, Machiela MJ.) Nat Commun. 2022 Sep 08;13(1):5284 PMID: 36075929 PMCID: PMC9458655 SCOPUS ID: 2-s2.0-85137561737 09/09/2022

• Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.

  (McReynolds LJ, Rafati M, Wang Y, Ballew BJ, Kim J, Williams VV, Zhou W, Hendricks RM, Dagnall C, Freedman ND, Carter B, Strollo S, Hicks B, Zhu B, Jones K, Paczesny S, Marsh SGE, Spellman SR, He M, Wang T, Lee SJ, Savage SA, Gadalla SM.) Blood. 2022 Aug 25;140(8):909-921 PMID: 35776903 PMCID: PMC9412004 SCOPUS ID: 2-s2.0-85136453763 07/02/2022

• A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation.

  (Arrieta-Bolaños E, Crivello P, He M, Wang T, Gadalla SM, Paczesny S, Marsh SGE, Lee SJ, Spellman SR, Bolon YT, Fleischhauer K.) Blood. 2022 Aug 11;140(6):659-663 PMID: 35609150 PMCID: PMC9373015 SCOPUS ID: 2-s2.0-85135926464 05/25/2022

• Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploidentical Stem Cell Transplantation.

  (Otegbeye F, Vina MAF, Wang T, Bolon YT, Lazaryan A, Beitinjaneh A, Bhatt VR, Castillo P, Marsh SGE, Hildebrandt GC, Assal A, Brown VI, Hsu J, Spellman S, de Lima M, Lee SJ.) Transplant Cell Ther. 2022 Aug;28(8):483.e1-483.e7 PMID: 35643351 PMCID: PMC9357149 SCOPUS ID: 2-s2.0-85135112985 06/02/2022